PAVmed (PAVM) Cash from Operations Growth (5y) (2020 - 2025)
PAVmed (PAVM) Cash from Operations Growth (5y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.47 Bn | 176.17 Bn | 6.27 Bn |
| 2 | Stryker | 129.01 Bn | 126.14 Bn | 3.81 Bn |
| 3 | Medtronic | 108.97 Bn | 99.75 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.46 Bn | 67.01 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.40 Bn | 44.73 Bn | 1.29 Bn |
| 6 | Dexcom | 28.37 Bn | 27.25 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.36 Bn | 26.07 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - |
| 9 | Koninklijke Philips | 25.46 Bn | 22.33 Bn | 2.07 Bn |
| 10 | PAVmed | 10.85 Mn | 9.31 Mn | -4,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 25.93% |
| Sep 30, 2025 | 31.20% |
| Jun 30, 2025 | 26.16% |
| Mar 31, 2025 | 16.05% |
| Dec 31, 2024 | 15.13% |
| Jun 30, 2024 | -35.85% |
| Mar 31, 2024 | -27.64% |
| Dec 31, 2023 | -31.50% |
| Sep 30, 2023 | -42.81% |
| Jun 30, 2023 | -49.50% |
| Mar 31, 2023 | -49.38% |
| Dec 31, 2022 | -60.35% |
| Sep 30, 2022 | -52.14% |
| Jun 30, 2022 | -93.87% |
| Mar 31, 2022 | -46.37% |
| Dec 31, 2021 | -69.39% |
| Sep 30, 2021 | -45.56% |
| Jun 30, 2021 | -34.49% |
| Mar 31, 2021 | -77.61% |
| Dec 31, 2020 | -59.68% |